APA (7th ed.) Citation

Kharfan-Dabaja, M. A., Wierda, W. G., & Cooper, L. J. N. (2014). Immunotherapy for chronic lymphocytic leukemia in the era of BTK inhibitors. Leukemia (08876924), 28(3), 507. https://doi.org/10.1038/leu.2013.311

Chicago Style (17th ed.) Citation

Kharfan-Dabaja, M A., W G. Wierda, and L J N. Cooper. "Immunotherapy for Chronic Lymphocytic Leukemia in the Era of BTK Inhibitors." Leukemia (08876924) 28, no. 3 (2014): 507. https://doi.org/10.1038/leu.2013.311.

MLA (9th ed.) Citation

Kharfan-Dabaja, M A., et al. "Immunotherapy for Chronic Lymphocytic Leukemia in the Era of BTK Inhibitors." Leukemia (08876924), vol. 28, no. 3, 2014, p. 507, https://doi.org/10.1038/leu.2013.311.